TLRY
Tilray Brands, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$3.03
−0.33%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$3.06
From 52W high−80.70%
Volume2.53M
Market cap$447.80M
P/E (TTM)—
P/S (TTM)0.5x
Div yield—
Key dataOct 19, 2026
Open
$3.06
From 52W high
−80.70%
Volume
2.53M
Market cap
$447.80M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−31.6x
P/E (TTM)
—
RSI (14)
25.0
MomentumView details →
1D Return
−0.33%
YTD Return
−66.28%
SummaryUpdated Aug 1, 2026
Tilray Brands, Inc. (NASDAQ:TLRY) is a Canadian multinational cannabis and consumer packaged goods company founded in 2013 and headquartered in Leamington, Ontario. Originally established as a medical cannabis producer, Tilray went public in 2018 and has since transformed into a diversified lifestyle brands company through strategic acquisitions and international expansion. The company operates across four main business segments: cannabis, beverage alcohol, distribution, and wellness products, serving markets in over 20 countries including Canada, the United States, Europe, Australia, and Latin America.
Similar companies
Latest newsMore news →
Tilray Brands, Inc. reported record first-quarter revenue of $257.1 million, up 23% year over year, with gross profit rising 35% to $77.5 million and gross margin expanding to 30% from 27%.11d agoTilray Brands, Inc. reported a first-quarter 2027 adjusted loss of $0.02 per share, compared with a consensus loss of $0.20 per share.11d agoTilray Brands reported a quarterly loss of $0.32 per share, compared with a loss of $0.19 per share expected by the Zacks Investment Research, Inc. consensus and break-even earnings per share a year earlier.11d ago